Invasive fungal diseases (IFDs) still represent a relevant cause of mortality in patients
affected by hematological malignancies, especially acute myeloid leukaemia (AML) and …

Post-induction aplasia for acute myeloid leukemia/myelodysplastic syndrome is a high-risk
period for invasive fungal diseases. The effectiveness of fluconazole, itraconazole solution …

Antifungal prophylaxis is the standard of care for patients undergoing intensive
chemotherapy for haematological malignancy or haematopoietic cell transplantation (HCT) …

Background Invasive fungal infection (IFI) causes high morbidity and mortality during acute
myeloid leukemia (AML) treatment. Interventions to prevent fungal infection, including air …

Background We evaluated the incidence of proven/probable invasive aspergillosis (IA) and
the role of antifungal prophylaxis (AP) in a 'real-life'setting of patients with AML receiving …

The D-index is calculated as the area over the neutrophil curve during neutropenia. We
investigated the impact of the D-index on pulmonary infection in 33 acute myeloid leukemia …

Introduction: Due to increasing intensity and complexity of therapies and longer survivorship,
many patients with haematologic malignancy (HM) are at risk of invasive fungal disease …

Background Fluconazole, posaconazole and voriconazole are used prophylactically in
patients with acute myeloid leukaemia (AML). This study evaluated the clinical and …

Invasive fungal infection (IFI) remains as a significant cause of morbidity and mortality in
patients with acute myelogenous leukemia (AML). Here, we report the subgroup analysis of …

Study Objective To determine whether granulocyte colony‐stimulating factor (G‐CSF)
prophylaxis after consolidation with high‐or intermediate‐dose cytarabine (H/IDAC) for …